Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 + T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients

Conroy MJ., Maher SG., Melo AM., Doyle SL., Foley E., Reynolds JV.

Prospective Study on Face & Skin, published in Front Immunol (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Front Immunol (2018)
Reported sample size
—
Source database
Europe PMC
PMID
30150990
PMCID
PMC6099201
DOI
10.3389/fimmu.2018.01867
Citations
26

Abstract (original English)

The omentum is enriched with pro-inflammatory effector memory CD8 + T cells in patients with the obesity-associated malignancy, esophagogastric adenocarcinoma (EAC) and we have identified the chemokine macrophage inflammatory protein-1alpha as a key player in their active migration to this inflamed tissue. More recently, others have established that subsets of memory CD8 + T cells can be classified based on their surface expression of CX3CR1; the specific receptor for the inflammatory chemokine fractalkine. CD8 + T cells expressing intermediate levels (CX3CR1 INT ) are defined as peripheral memory, those expressing the highest levels (CX3CR1 HI ) are effector memory/terminally differentiated and those lacking CX3CR1 (CX3CR1 NEG ) are classified as central memory. To date, the fractalkine:CX3CR1 axis has not been examined in the context of CD8 + T cell enrichment in the omentum and here we examine this chemokines involvement in the accumulation of memory CD8 + T cells in the omentum of EAC patients. Our data show that fractalkine is significantly enriched in the omentum of EAC patients and drives migration of T cells derived from EAC patient blood. Furthermore, CX3CR1 is endocytosed specifically by CD8 + T cells upon encountering fractalkine, which is consistent with the significantly diminished frequencies of CX3CR1 INT and CX3CR1 HI CD8 + T cells in the fractalkine-rich enviro

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
OmentumCD8-Positive T-LymphocytesCells, CulturedHumansNeoplasmsObesityL-SelectinCell ProliferationCell MovementImmunologic Memory

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research